Analystreport

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its price target raised by analysts at HC Wainwright from $29.00 to $33.00. They now have a "buy" rating on the st

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com